Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PATHFINDER Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (EX-PAD-05)

NCT04229563 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT04229563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04229563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PATHFINDER Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (EX-PAD-05)
Lead sponsor
Angiodynamics, Inc.
Phase
Observational
Overall status
Completed
Start date
August 4, 2020
Completion date
April 17, 2023
Enrollment
102 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

infrainguinal peripheral artery disease, pad, peripheral arterial disease